Gainers
- Eloxx Pharmaceuticals ELOX shares increased by 12.25% to $0.74 during Thursday's after-market session. The company's market cap stands at $63.8 million.
- Idera Pharmaceuticals IDRA stock increased by 8.85% to $0.67. The market value of their outstanding shares is at $35.1 million.
- Avalon Globocare AVCO stock rose 5.65% to $0.9. The company's market cap stands at $77.1 million.
- Chemomab Therapeutics CMMB stock rose 5.48% to $7.31. The company's market cap stands at $83.3 million.
- Rockwell Medical RMTI stock moved upwards by 5.44% to $0.42. The company's market cap stands at $39.4 million.
- LHC Group LHCG shares moved upwards by 4.34% to $130.0. The market value of their outstanding shares is at $4.1 billion.
Losers
- Abeona Therapeutics ABEO stock declined by 28.3% to $0.35 during Thursday's after-market session. Trading volume for this security closed at 725.2K, accounting for 88.61% of its average full-day volume over the last 100 days. The company's market cap stands at $35.6 million.
- Great Elm Group GEG shares decreased by 23.47% to $1.5. The company's market cap stands at $40.3 million.
- Kaleido Biosciences KLDO shares declined by 6.65% to $2.81. The company's market cap stands at $119.6 million.
- Exicure XCUR shares decreased by 4.27% to $0.25. At the close, Exicure's trading volume reached 200.7K shares. This is 14.16% of its average volume over the last 100 days. The company's market cap stands at $21.9 million.
- Forward Pharma FWP stock decreased by 3.84% to $5.77. The market value of their outstanding shares is at $40.4 million.
- Enveric Biosciences ENVB shares declined by 3.74% to $1.03. The market value of their outstanding shares is at $32.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in